---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-001240"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2025-07-18T23:59:59+00:00"
generated_at: "2026-05-18T05:44:27.390694+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences enters $6.5M at-the-market equity offering with R.F. Lafferty

## Summary
- Agreement with R.F. Lafferty & Co. to sell up to $6.5M of common stock via ATM program.
- Manager commission: 2.0% of gross sales price per share; Company may set minimum price.
- Offering can be suspended by either party on 5 days' notice; Company has no obligation to sell.
- Based on existing Form S-3 shelf effective July 14, 2023; prospectus supplement filed July 18, 2025.

## SEC filing metadata
- accession: 0001640334-25-001240
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2025-07-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001240/0001640334-25-001240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001240/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-001240
- JSON: https://secwatch.observer/filing/0001640334-25-001240.json
- Plain text: https://secwatch.observer/filing/0001640334-25-001240.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.